LS SECURITIES Co., Ltd. (KOSDAQ:078020)
South Korea
· Delayed Price · Currency is KRW 8,000.00
+130.00 (1.65%)
At close: Apr 28, 2026
LS SECURITIES Revenue
In the year 2025, LS SECURITIES had annual revenue of 2.09T KRW with 47.52% growth. LS SECURITIES had revenue of 915.52B in the quarter ending December 31, 2025, with 148.53% growth.
Revenue
2,088.77B
Revenue Growth
+47.52%
P/S Ratio
0.19
Revenue / Employee
6.49B
Employees
322
Market Cap
403.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2,088.77B | 672.89B | 47.52% |
| Dec 31, 2024 | 1,415.87B | 271.78B | 23.76% |
| Dec 31, 2023 | 1,144.09B | -94.92B | -7.66% |
| Dec 31, 2022 | 1,239.01B | -246.61B | -16.60% |
| Dec 31, 2021 | 1,485.62B | -457.07B | -23.53% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LIG Accuver | 186.10B |
| Helixmith | 2.60B |
| GABIA | 335.68B |
| APACT | 111.00B |
| Kangstem Biotech | 3.57B |
| UniTest Incorporation | 110.20B |
| Mecaro | 94.61B |
| JEIO Co., Ltd. | 55.17B |